Related Experiment Video
Updated: Oct 21, 2025
12:08
Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
19.0K
[Polypharmacy : the method and tools for medication review]
Baptiste Miaz1, Maria De Brito Nunes1, Marco Mancinetti1
1Service de médecine interne, HFR Fribourg, 1752 Villars-sur-Glâne.
Revue Medicale Suisse
|September 8, 2021
Summary
Polypharmacy and potentially inappropriate medications (PIM) pose significant public health risks. Medication reviews, utilizing tools like Beers criteria and STOPP/START, can help reduce PIM, especially in elderly patients.
Area of Science:
- Geriatric Medicine
- Clinical Pharmacy
- Public Health
Background:
- Polypharmacy and potentially inappropriate medications (PIM) are significant public health issues.
- These issues are linked to increased mortality, morbidity, and socioeconomic costs.
- PIM is particularly prevalent in elderly individuals and those with multiple comorbidities.
Purpose of the Study:
- To highlight the public health concerns of polypharmacy and PIM.
- To present medication review as a strategy to mitigate PIM.
- To introduce key tools that support medication review processes.
Main Methods:
- Review of existing literature and established guidelines.
- Introduction of the Beers criteria.
- Introduction of the PRISCUS list.
- Introduction of the STOPP/START criteria.
- Introduction of the Medication Appropriateness Index (MAI).
- Introduction of the Good-Palliative-Geriatric Practice Algorithm.
Main Results:
- Several validated tools exist to aid in medication review.
- These tools assist in identifying and reducing PIM.
- Effective medication review can improve patient outcomes and reduce healthcare burden.
Conclusions:
- Medication review is a crucial intervention for managing PIM.
- The discussed tools provide a framework for systematic medication assessment.
- Implementing these tools can enhance geriatric care and patient safety.
Related Concept Videos
01:15Drug Dosing: Geriatric Patients
34
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
34
01:28Drug Therapy
119
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
119
01:28Dosage Regimens: Designs and Approaches
45
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
45
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
28
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
28
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
29
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
29
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
26
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
26